Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,279 | 628 | 99.1% |
| Education | $100.27 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,005 | 102 | $0 (2024) |
| Janssen Biotech, Inc. | $909.09 | 73 | $0 (2024) |
| LEO Pharma Inc. | $907.05 | 52 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $813.19 | 45 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $703.09 | 33 | $0 (2024) |
| PFIZER INC. | $701.23 | 50 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $507.52 | 27 | $0 (2024) |
| Amgen Inc. | $439.59 | 25 | $0 (2024) |
| Lilly USA, LLC | $425.76 | 23 | $0 (2024) |
| Galderma Laboratories, L.P. | $407.74 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,033 | 94 | SUN PHARMACEUTICAL INDUSTRIES INC. ($309.59) |
| 2023 | $1,653 | 84 | ABBVIE INC. ($221.30) |
| 2022 | $1,832 | 111 | Janssen Biotech, Inc. ($327.45) |
| 2021 | $1,414 | 70 | AbbVie Inc. ($328.83) |
| 2020 | $895.32 | 52 | AbbVie Inc. ($295.63) |
| 2019 | $1,289 | 76 | AbbVie, Inc. ($237.52) |
| 2018 | $1,363 | 87 | AbbVie, Inc. ($206.22) |
| 2017 | $900.13 | 56 | Galderma Laboratories, L.P. ($121.04) |
All Payment Transactions
630 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Immunology | ||||||
| 12/23/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Dermatology | ||||||
| 12/22/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.08 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.06 | General |
| 12/04/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.76 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $32.77 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug), DUOBRII | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: DERMATOLOGY | ||||||
| 10/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.65 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $2.83 | General |
| Category: DERMATOLOGY | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Inflammation | ||||||
| 09/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,400 | 3,545 | $689,290 | $184,683 |
| 2022 | 16 | 2,274 | 3,345 | $620,065 | $168,062 |
| 2021 | 15 | 2,751 | 4,279 | $732,616 | $206,131 |
| 2020 | 20 | 3,045 | 4,646 | $498,743 | $216,509 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 658 | 751 | $172,730 | $49,913 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 383 | 447 | $147,510 | $42,447 | 28.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 246 | 289 | $80,920 | $21,749 | 26.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 389 | 485 | $97,000 | $21,579 | 22.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 45 | 45 | $38,475 | $11,532 | 30.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 118 | 134 | $42,880 | $11,314 | 26.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 241 | 968 | $19,360 | $5,516 | 28.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 36 | 37 | $25,900 | $3,982 | 15.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 87 | 90 | $13,050 | $3,594 | 27.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $8,495 | $2,655 | 31.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 35 | 50 | $7,500 | $2,011 | 26.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 14 | 15 | $5,775 | $1,849 | 32.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 13 | $6,500 | $1,808 | 27.8% |
| 96900 | Application of ultraviolet light to skin | Office | 2023 | 14 | 74 | $7,400 | $1,492 | 20.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 32 | 37 | $5,735 | $1,304 | 22.7% |
| 11601 | Removal of cancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 12 | 12 | $7,740 | $1,208 | 15.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $2,035 | $687.72 | 33.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 37 | 57 | $285.00 | $42.42 | 14.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 657 | 747 | $171,810 | $50,016 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 353 | 395 | $130,350 | $36,211 | 27.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 382 | 475 | $95,000 | $21,326 | 22.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 230 | 260 | $71,940 | $19,729 | 27.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 112 | 117 | $35,780 | $10,308 | 28.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 30 | 33 | $27,365 | $8,676 | 31.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 236 | 1,005 | $20,100 | $5,838 | 29.0% |
About Dr. Grace Federman, MD
Dr. Grace Federman, MD is a Dermatology healthcare provider based in Danbury, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033160924.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Grace Federman, MD has received a total of $11,380 in payments from pharmaceutical and medical device companies, with $2,033 received in 2024. These payments were reported across 630 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($11,279).
As a Medicare-enrolled provider, Federman has provided services to 10,470 Medicare beneficiaries, totaling 15,815 services with total Medicare billing of $775,384. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Danbury, CT
- Active Since 05/15/2006
- Last Updated 03/21/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1033160924
Products in Payments
- SKYRIZI (Biological) $964.42
- EUCRISA (Drug) $649.39
- Humira (Biological) $526.06
- REMICADE (Biological) $523.19
- DUPIXENT (Biological) $518.40
- ENSTILAR (Drug) $433.37
- TALTZ (Drug) $405.07
- COSENTYX (Biological) $356.60
- ADBRY (Biological) $342.27
- Otezla (Drug) $340.30
- TREMFYA (Drug) $326.98
- RINVOQ (Biological) $294.13
- JUBLIA (Drug) $289.33
- ILUMYA (Biological) $268.38
- OPZELURA (Drug) $266.44
- Cimzia (Drug) $205.54
- EPIDUO FORTE (Drug) $183.06
- CLODERM (Drug) $181.23
- Bimzelx (Biological) $159.60
- DUOBRII (Drug) $146.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Danbury
Ms. Mona Gohara, Md, MD
Dermatology — Payments: $243,572
William Notaro, Md, MD
Dermatology — Payments: $74,888
Mr. Graeme Lipper, Md, MD
Dermatology — Payments: $26,582
Mr. Jonathan Zirn, Md, MD
Dermatology — Payments: $15,406
Dr. Marimeg Clairwood, M.d, M.D
Dermatology — Payments: $5,407
Dmitriy Timerman
Dermatology — Payments: $4,673